Jerusalem Pharmaceuticals Statistics
Total Valuation
PEX:JPH has a market cap or net worth of JOD 59.30 million. The enterprise value is 45.52 million.
| Market Cap | 59.30M |
| Enterprise Value | 45.52M |
Important Dates
The next estimated earnings date is Tuesday, March 10, 2026.
| Earnings Date | Mar 10, 2026 |
| Ex-Dividend Date | Apr 30, 2025 |
Share Statistics
PEX:JPH has 18.00 million shares outstanding. The number of shares has increased by 0.08% in one year.
| Current Share Class | 18.00M |
| Shares Outstanding | 18.00M |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 42.30% |
| Owned by Institutions (%) | 6.39% |
| Float | 6.90M |
Valuation Ratios
The trailing PE ratio is 8.19.
| PE Ratio | 8.19 |
| Forward PE | n/a |
| PS Ratio | 1.68 |
| PB Ratio | 0.95 |
| P/TBV Ratio | 0.99 |
| P/FCF Ratio | 56.36 |
| P/OCF Ratio | 23.63 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.28, with an EV/FCF ratio of 43.26.
| EV / Earnings | 6.28 |
| EV / Sales | 1.29 |
| EV / EBITDA | 4.28 |
| EV / EBIT | 4.98 |
| EV / FCF | 43.26 |
Financial Position
The company has a current ratio of 4.27, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.27 |
| Quick Ratio | 3.36 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | 0.89 |
| Interest Coverage | 45.80 |
Financial Efficiency
Return on equity (ROE) is 12.90% and return on invested capital (ROIC) is 14.42%.
| Return on Equity (ROE) | 12.90% |
| Return on Assets (ROA) | 7.99% |
| Return on Invested Capital (ROIC) | 14.42% |
| Return on Capital Employed (ROCE) | 13.54% |
| Weighted Average Cost of Capital (WACC) | 4.35% |
| Revenue Per Employee | 66,669 |
| Profits Per Employee | 13,662 |
| Employee Count | 531 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 2.11 |
Taxes
In the past 12 months, PEX:JPH has paid 1.93 million in taxes.
| Income Tax | 1.93M |
| Effective Tax Rate | 20.90% |
Stock Price Statistics
The stock price has increased by +23.02% in the last 52 weeks. The beta is -0.02, so PEX:JPH's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | +23.02% |
| 50-Day Moving Average | 4.47 |
| 200-Day Moving Average | 3.98 |
| Relative Strength Index (RSI) | 55.94 |
| Average Volume (20 Days) | 2,035 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PEX:JPH had revenue of JOD 35.40 million and earned 7.25 million in profits. Earnings per share was 0.40.
| Revenue | 35.40M |
| Gross Profit | 19.40M |
| Operating Income | 9.14M |
| Pretax Income | 9.24M |
| Net Income | 7.25M |
| EBITDA | 10.47M |
| EBIT | 9.14M |
| Earnings Per Share (EPS) | 0.40 |
Balance Sheet
The company has 15.49 million in cash and 937,527 in debt, giving a net cash position of 14.56 million or 0.81 per share.
| Cash & Cash Equivalents | 15.49M |
| Total Debt | 937,527 |
| Net Cash | 14.56M |
| Net Cash Per Share | 0.81 |
| Equity (Book Value) | 62.54M |
| Book Value Per Share | 3.42 |
| Working Capital | 39.91M |
Cash Flow
In the last 12 months, operating cash flow was 2.51 million and capital expenditures -1.46 million, giving a free cash flow of 1.05 million.
| Operating Cash Flow | 2.51M |
| Capital Expenditures | -1.46M |
| Free Cash Flow | 1.05M |
| FCF Per Share | 0.06 |
Margins
Gross margin is 54.81%, with operating and profit margins of 25.82% and 20.49%.
| Gross Margin | 54.81% |
| Operating Margin | 25.82% |
| Pretax Margin | 26.10% |
| Profit Margin | 20.49% |
| EBITDA Margin | 29.57% |
| EBIT Margin | 25.82% |
| FCF Margin | 2.97% |
Dividends & Yields
This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 1.72%.
| Dividend Per Share | 0.06 |
| Dividend Yield | 1.72% |
| Dividend Growth (YoY) | -19.95% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 8.01% |
| Buyback Yield | -0.08% |
| Shareholder Yield | 1.64% |
| Earnings Yield | 12.23% |
| FCF Yield | 1.77% |
Stock Splits
The last stock split was on August 1, 2013. It was a forward split with a ratio of 1.4216864044.
| Last Split Date | Aug 1, 2013 |
| Split Type | Forward |
| Split Ratio | 1.4216864044 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |